![Peter Hovstadius](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Hovstadius
Hoofd Techniek/Wetenschap/O&O bij
LIPUM AB
Profiel
Peter Hovstadius currently works at Lipum AB, as Chief Medical Officer from 2024.
Dr. Hovstadius also formerly worked at Merck Sharp & Dohme AB, as Research Director, XNK Therapeutics AB, as Chief Medical Officer, and Novartis Sverige AB, as Chief Scientific Officer.
Dr. Hovstadius received his doctorate degree from the University of Uppsala.
Actieve functies van Peter Hovstadius
| Bedrijven | Functie | Begin |
|---|---|---|
| LIPUM AB | Hoofd Techniek/Wetenschap/O&O | 19-08-2024 |
Eerdere bekende functies van Peter Hovstadius
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Hoofd Techniek/Wetenschap/O&O | - |
Merck Sharp & Dohme AB | Hoofd Techniek/Wetenschap/O&O | - |
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Peter Hovstadius
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Health Technology |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Health Technology |
Lipum AB
 Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
Merck Sharp & Dohme AB |
